1 |
glucose homeostasis |
GO:0042593 |
10.21 |
LEP INS IL6 ADIPOQ |
2 |
positive regulation of apoptotic process |
GO:0043065 |
10.14 |
MIR29A MIR27A MIR221 MIR21 IL6 |
3 |
positive regulation of gene expression |
GO:0010628 |
10.14 |
MIR34A MIR29A MIR27A MIR223 MIR21 MIR17 |
4 |
response to activity |
GO:0014823 |
10.13 |
LEP IL6 ADIPOQ |
5 |
acute-phase response |
GO:0006953 |
10.11 |
SERPINA3 INS IL6 |
6 |
positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0014068 |
10.06 |
MIR21 MIR126 LEP INS |
7 |
cellular response to lipopolysaccharide |
GO:0071222 |
10.05 |
MIR223 MIR21 MIR17 MIR140 IL6 |
8 |
regulation of angiogenesis |
GO:0045765 |
10.03 |
IL6 LEP MIR199A1 |
9 |
negative regulation of cell migration |
GO:0030336 |
10.03 |
MIR34A MIR29A MIR21 MIR126 ADIPOQ |
10 |
positive regulation of glucose import |
GO:0046326 |
10.02 |
ADIPOQ INS MIR223 |
11 |
positive regulation of receptor signaling pathway via JAK-STAT |
GO:0046427 |
10.02 |
MIR221 LEP IL6 |
12 |
negative regulation of inflammatory response |
GO:0050728 |
9.98 |
ADIPOQ MIR126 MIR142 MIR199A1 MIR221 MIR223 |
13 |
positive regulation of protein kinase B signaling |
GO:0051897 |
9.97 |
INS LEP MIR126 MIR199A1 MIR21 MIR221 |
14 |
positive regulation of epithelial to mesenchymal transition |
GO:0010718 |
9.96 |
MIR221 MIR21 IL6 |
15 |
cellular response to hypoxia |
GO:0071456 |
9.94 |
MIR34A MIR17 MIR140 MIR126 |
16 |
positive regulation of cytokine production involved in inflammatory response |
GO:1900017 |
9.9 |
MIR21 MIR17 IL6 |
17 |
negative regulation of vascular associated smooth muscle cell proliferation |
GO:1904706 |
9.89 |
MIR34A MIR223 MIR140 ADIPOQ |
18 |
negative regulation of low-density lipoprotein receptor activity |
GO:1905598 |
9.85 |
MIR27A ADIPOQ |
19 |
negative regulation of gene expression |
GO:0010629 |
9.85 |
MIR34A MIR29A MIR27A MIR21 MIR199A1 MIR17 |
20 |
positive regulation of vascular associated smooth muscle cell proliferation |
GO:1904707 |
9.81 |
MIR27A MIR221 MIR21 MIR17 |
21 |
negative regulation of interleukin-1-mediated signaling pathway |
GO:2000660 |
9.78 |
MIR27A MIR21 IL6 |
22 |
positive regulation of vascular endothelial cell proliferation |
GO:1905564 |
9.76 |
MIR29A MIR27A MIR21 MIR126 |
23 |
negative regulation of sprouting angiogenesis |
GO:1903671 |
9.74 |
MIR34A MIR221 MIR17 |
24 |
miRNA-mediated gene silencing by inhibition of translation |
GO:0035278 |
9.73 |
MIR29A MIR27A MIR221 MIR21 MIR17 MIR126 |
25 |
miRNA-mediated gene silencing by mRNA destabilization |
GO:0035279 |
9.72 |
MIR27A MIR223 MIR140 |
26 |
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO:1903589 |
9.71 |
MIR126 MIR21 MIR27A |
27 |
negative regulation of low-density lipoprotein particle clearance |
GO:0010989 |
9.7 |
MIR27A MIR199A1 MIR17 |
28 |
positive regulation of connective tissue replacement |
GO:1905205 |
9.67 |
MIR34A MIR199A1 |
29 |
negative regulation of vascular endothelial growth factor production |
GO:1904046 |
9.67 |
MIR34A MIR199A1 MIR17 MIR140 |
30 |
positive regulation of cardiac muscle hypertrophy in response to stress |
GO:1903244 |
9.65 |
MIR17 MIR199A1 |
31 |
negative regulation of vascular associated smooth muscle cell apoptotic process |
GO:1905460 |
9.65 |
MIR21 MIR17 |
32 |
miRNA-mediated gene silencing |
GO:0035195 |
9.64 |
MIR34A MIR29A MIR27A MIR223 MIR221 MIR21 |
33 |
positive regulation of metalloendopeptidase activity |
GO:1904685 |
9.63 |
MIR21 MIR17 |
34 |
negative regulation of BMP secretion |
GO:2001285 |
9.61 |
MIR17 MIR140 |
35 |
negative regulation of interleukin-21 production |
GO:0032705 |
9.59 |
MIR21 MIR221 |
36 |
negative regulation of vascular associated smooth muscle cell migration |
GO:1904753 |
9.43 |
ADIPOQ MIR140 MIR21 MIR223 MIR34A |